Middle East & Africa ECG Devices Market Analysis and Forecast by Size, Share, Growth, Trends 2031

The Middle East & Africa ECG devices market size is expected to reach US$ 166.87 million by 2031 from US$ 132.97 million in 2024. The market is estimated to record a CAGR of 3.3% from 2024 to 2031.

Executive Summary and Middle East & Africa ECG Devices Market Analysis:

The ECG devices market in the Middle East & Africa is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. The market in this region is driven by factors such as the rising prevalence of coronary artery disease, the increasing geriatric population, and partnerships with private organizations. Furthermore, advancements in healthcare technology, growing healthcare spending, and government initiatives aimed at improving healthcare infrastructure are expected to accelerate market growth in the coming years.

Middle East & Africa ECG Devices Market: Strategic Insights

Middle East & Africa ECG Devices Market Segmentation Analysis:

Key segments that contributed to the derivation of the Middle East & Africa ECG devices market analysis are product, lead type, technology, and end user.

• Based on product, the Middle East & Africa ECG devices market is bifurcated into resting ECG and stress ECG. The resting ECG segment held a larger share of the market in 2024.

• By lead type, the Middle East & Africa ECG devices market is segmented into 12-lead ECG, 3-6 lead ECG, and single lead. The 12-lead ECG segment held the largest share of the market in 2024.

• Based on technology, the Middle East & Africa ECG devices market is bifurcated into portable (Wired) ECG system and wireless ECG system. The wireless ECG system segment held a larger share of the market in 2024.

• Based on end user, the Middle East & Africa ECG devices market is segmented into hospital and clinics, ambulatory surgical centers, cardiac centers and others. The hospital and clinics segment held the largest share of the market in 2024.

Middle East & Africa ECG Devices Market Players Density: Understanding Its Impact on Business Dynamics

The Middle East & Africa ECG Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Middle East & Africa ECG Devices Market Outlook

According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are among the leading causes of death worldwide. The most prevalent disease among all cardiovascular diseases is coronary artery disease (CAD), characterized by the accumulation of lipids and immune cells in the subendothelial area of the coronary arteries, which is also known as atherosclerosis. It can lead to hypoxia, ischemia, or necrosis of the myocardium resulting from narrowing, spasm, or obstruction of the coronary artery lumen. According to the American Heart Association, CVDs account for 19.91 million global deaths in 2021. According to the World Heart Federation, CVDs accounted for more than a third of all deaths, i.e., 1.4 million people in the Middle East and North Africa. Further, CVD deaths have increased by 48% over the past 30 years, accounting for 40% and 10% of deaths in Oman and Somalia, respectively. According to the American College of Cardiology Foundation report, in 2021, CVD mortality rates in the Middle East and North Africa were from 134.2 to 600.2 per 100,000 people.

As ECG devices help in effectively diagnosing irregular heartbeats due to blocked or narrowed heart arteries, the high prevalence of cardiovascular diseases promotes the use of these devices, thereby bolstering its market growth.

Middle East & Africa ECG Devices Market Country Insights

Based on country, the Middle East & Africa ECG devices market comprises Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. South Africa held the largest share in 2024.

South Africa is one of the major economies in the Middle East and Africa; the country had a GDP of US$ 377.78 billion in 2023, and healthcare accounted for the second-largest share (~8.5%) of the overall GDP. This growth in healthcare expenditure creates favorable conditions for the expansion of the ECG devices market within the country. In South Africa, CVD constitutes the second leading cause of mortality after HIV/AIDS. According to the Heart and Stroke Foundation of South Africa, CVD is responsible for roughly 1 in 6 deaths (17.3%); also, 215 people die either from heart disease or strokes every day in the country. According to the National Library of Medicine Report 2020, the prevalence rate of atrial fibrillation and atrial flutter is 16-22% in heart failure, 10-28% in rheumatic heart disease, and 3-7% in cardiology admissions in Sub-Saharan Africa. With CVD being a leading cause of mortality in the country, there is a rising demand for diagnostic tools, such as ECGs, to enable early detection and management of heart-related conditions.

Government initiatives and partnerships with private organizations and the adoption of telemedicine are addressing healthcare challenges and expanding access to medical technologies. The National Department of Health has been working to strengthen healthcare infrastructure through programs like the National Health Insurance (NHI) system, which aims to provide universal healthcare coverage and improve access to medical services. While the implementation of the NHI is still in progress, it has the potential to increase the adoption of medical devices such as ECGs in remote and less accessible areas.

Middle East & Africa ECG Devices Market Company Profiles

Some of the key players operating in the market include GE HealthCare Technologies Inc; Spacelabs Healthcare; Nihon Kohden Corp; Schiller AG; Hill-Rom Holdings Inc; BPL Medical Technologies Pvt Ltd; Koninklijke Philips NV; AliveCor, Inc; FUKUDA DENSHI; EB Neuro S.P.A; Shenzhen Mindray Bio-Medical Electronics Co Ltd; Viatom Technology Co., Ltd.; CompuMed Inc.; Norav Medical; and custo med GmbH, among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Middle East & Africa ECG Devices Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations.

• Industry trade journals and other relevant publications.

• Government documents, statistical databases, and market reports.

• News articles, press releases, and webcasts specific to companies operating in the market.

Note:

All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners' conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research.

• Enhance the expertise and market understanding of the analysis team.

• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers

• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise